Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel for Acute Radiation-Induced Diarrhea
2016-001790-33Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lanreotide in radiation enteritis, sponsored by Ghent University Hospital. Primary endpoints: Complete response rate and Partial response rate. Started May 2016; status: completed.
02
Drugs
lanreotide
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on 2016-001790-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001790-33.